JeremyKortmanskyMD

PubMed

• Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
  John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Beal, Richard S Finn, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishm...> ;Journal of Clinical Oncology. 2024 Mar 19
• NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
  Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha, May Cho, Anthony Shields, Shubham Pant, Laura Goff, Kristen Spencer, Edward Kim, Stacey Stein, ...> ;British Journal of Cancer. 2024 Feb 1
• Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer.
  Gabrielle W Peters, Wesley Talcott, Nicholas V Peters, Andrew Dhanasopan, Jill Lacy, Michael Cecchini, Jeremy Kortmansky, Stacey Stein, Stephen Lattanzi, Daniel Boffa,...> ;Journal of Gastrointestinal Oncology. 2023 Jun 30
• Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
  Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kort...> ;Cancer Research Communications. 2023 Jun 1
• 16 citations
  Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias.
  Andrew R. Branagan, Eamon Duffy, Geliang Gan, Fangyong Li, Connor Foster, Rakesh Verma, Lin Zhang, Terri L. Parker, Stuart Seropian, Dennis L. Cooper, Debra Brandt, Je...> ;Blood Advances. 2021 Mar 9
• 5 citations
  Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national c...
  Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol ...> ;Clinical and Translational Radiation Oncology. 2021 Mar 1
• 5 citations
  A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
  Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar, Nataliya Volodymyrivna Uboha, Navid Hafez, Jill Lacy, Neal A. Fischbach, Kert D. Sabbath,...> ;Cancer. 2020 Dec 22
• 304 citations
  Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
  John D. Gordan, Erin B. Kennedy, Ghassan K. Abou-Alfa, Muhammad Shaalan Beg, Steven Brower, Terence P. Gade, Laura W. Goff, Shilpi Singh Gupta, Jennifer File Guy, Will...> ;Journal of Clinical Oncology. 2020 Nov 16
• 2 citations
  A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline ...
  Michael Cecchini, Joseph A. Miccio, Jay Pahade, Jill Lacy, Ronald R. Salem, Skyler B. Johnson, Adriana Blakaj, Stacey Stein, Jeremy S. Kortmansky, Kimberly L. Johung> ;Pancreas. 2020 Aug 1
• 6 citations
  Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Out...
  Manish A. Shah, Peter C. Enzinger, Andrew H. Ko, Allyson J. Ocean, Philip A. Philip, Prashant V. Thakkar, Kyle Cleveland, Yao Lu, Jeremy S. Kortmansky, Paul J. Christo...> ;Clinical Cancer Research. 2020 Jul 8
• 175 citations
  Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma...
  Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy, Jeremy S. Kortmansky, Jaykumar Ranchodbhai Thumar, E. Gabriela Chiorean, Anth...> ;Journal of Clinical Oncology. 2019 Feb 28
• 9 citations
  Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction
  Anne C. Chiang, Jessica Lake, Naralys Sinanis, Debra S. Brandt, Jane Kanowitz, Wajih Zaheer Kidwai, Jeremy S. Kortmansky, Johanna LaSala, Jeffrey Orell, Kert D. Sabbat...> ;Journal of Oncology Practice. 2018 Dec 11
• 8 citations
  Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.
  Jia Li, Xiaopan Yao, Jeremy S. Kortmansky, Neal A. Fischbach, Stacey Stein, Yanhong Deng, Yue Zhang, Indukala Doddamane, David Karimeddini, Howard S. Hochster, Jill Lacy> ;American Journal of Clinical Oncology. 2017 Apr 1
• 144 citations
  Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
  Stacey Stein, Edward Samuel James, Yanhong Deng, Xiangyu Cong, Jeremy S. Kortmansky, Jia Li, Carol Staugaard, Doddamane Indukala, Ann Marie Boustani, Vatsal Patel, Cha...> ;British Journal of Cancer. 2016 Mar 1
• 28 citations
  A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.
  Richard D. Carvajal, Archie Tse, Manish A. Shah, Robert A. Lefkowitz, Mithat Gonen, Lisa Gilman-Rosen, Jeremy S. Kortmansky, David P. Kelsen, Gary K. Schwartz, Eileen ...> ;Pancreatology. 2009 Jun 1
• 60 citations
  A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma
  Austin G. Duffy, Jeremy S. Kortmansky, Gary K. Schwartz, Marinela Capanu, S. A. Puleio, Bruce D. Minsky, Leonard B. Saltz, David P. Kelsen, Eileen M. O'Reilly> ;Annals of Oncology. 2007 Jan 1
• 247 citations
  A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
  Ignacio Duran, J. Kortmansky, D. Singh, H. Hirte, Walter Kocha, Glenwood D. Goss, Lisa W. Le, Amit M. Oza, Trudey Nicklee, James Ho, Diana C. Birle, Gregory R. Pond, A...> ;British Journal of Cancer. 2006 Nov 6
• A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs).
  Duran I, Le L, Saltman D, Kortmansky J, Kocha W, Singh D, Pond GR, Peralba JM, Dancey J, Siu LL> ;J. Clin. Oncol.. 2005-06-01
• A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
  Kortmansky JS, O'Reilly EM, Minsky BD, Puleio SA, Winkelmann J, Kelsen DP, Schwartz GK> ;J. Clin. Oncol.. 2005-06-01
• A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: promising activity in metastatic pancreatic cancer.
  Rathkopf D, Fornier M, Shah MA, Kortmansky J, O'Reilly E, Winkelmann J, Balzano L, Kelsen DP, Schwartz GK> ;J. Clin. Oncol.. 2005-06-01
• 71 citations
  A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol
  Manish A. Shah, Jeremy S. Kortmansky, Monica Motwani, Marija Drobnjak, Mithat Gonen, Sandy Yi, Amanda R. Weyerbacher, Carlos Cordon-Cardo, Robert A. Lefkowitz, Baruch ...> ;Clinical Cancer Research. 2005 May 15
• 87 citations
  Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced...
  Jeremy S. Kortmansky, Manish A. Shah, Andreas Kaubisch, Amanda R. Weyerbacher, Sandy Yi, William P. Tong, Rebecca Sowers, Mithat Gonen, Eileen M. O'Reilly, Nancy E. Ke...> ;Journal of Clinical Oncology. 2005 Mar 20
• Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil.
  Kortmansky JS, Sauter N, O'Reilly E, Shah M, Abou-Alfa GK, Winkelmann J, Yi S, Gonen M, Kelsen DP, Schwartz GK> ;J. Clin. Oncol.. 2004-07-15
• A phase I study of weekly irinotecan (CPT), cisplatin (CIS) and flavopiridol (F).
  Shah MA, Kortmansky J, Gonen M, Tse A, Lefkowitz R, Kelsen D, Colevas D, Winkelman J, Yi S, Schwartz G> ;J. Clin. Oncol.. 2004-07-15
• A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors.
  Rathkopf D, Fornier M, Shah M, Kortmansky J, O'Reilly E, King A, Winkelmann J, Kelsen DP, Olsen S, Schwartz GK> ;J. Clin. Oncol.. 2004-07-15
• Join now to see all